Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125200811 | 12520081 | 1 | I | 201603 | 20160623 | 20160701 | 20160701 | EXP | IE-AMGEN-IRLSL2016083765 | AMGEN | 75.00 | YR | E | M | Y | 0.00000 | 20160701 | OT | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125200811 | 12520081 | 1 | PS | ARANESP | DARBEPOETIN ALFA | 1 | Other | 60 MUG, QMO | 103951 | 60 | UG | SOLUTION FOR INJECTION | /month | ||||||
| 125200811 | 12520081 | 2 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Other | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 125200811 | 12520081 | 3 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Other | 75 MG, QD | 0 | 75 | MG | QD | |||||||
| 125200811 | 12520081 | 4 | C | BISOPROLOL | BISOPROLOL | 1 | Other | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 125200811 | 12520081 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Other | 40 MG, BID | 0 | 40 | MG | BID | |||||||
| 125200811 | 12520081 | 6 | C | GALFER | IRON | 1 | Other | 305 MG, QD | 0 | 305 | MG | QD | |||||||
| 125200811 | 12520081 | 7 | C | IMDUR | ISOSORBIDE MONONITRATE | 1 | Other | 60 MG, QD | 0 | 60 | MG | QD | |||||||
| 125200811 | 12520081 | 8 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Other | 4 MG, QD | 0 | 4 | MG | QD | |||||||
| 125200811 | 12520081 | 9 | C | ONE ALPHA | ALFACALCIDOL | 1 | Other | 0.25 MUG, ON ALTERNATE DAYS | 0 | .25 | UG | ||||||||
| 125200811 | 12520081 | 10 | C | CALCIUM ACETATE. | CALCIUM ACETATE | 1 | Other | 1000 UNK, QD | 0 | QD | |||||||||
| 125200811 | 12520081 | 11 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | Other | 1200 MG, QD | 0 | 1200 | MG | QD | |||||||
| 125200811 | 12520081 | 12 | C | MINOXIDIL. | MINOXIDIL | 1 | Other | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 125200811 | 12520081 | 13 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | Other | 20 MG, QD | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125200811 | 12520081 | 1 | Diabetic nephropathy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125200811 | 12520081 | HO |
| 125200811 | 12520081 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125200811 | 12520081 | Haemoglobin abnormal | |
| 125200811 | 12520081 | Lung infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125200811 | 12520081 | 1 | 20121031 | 0 |